Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Mudan

Neutrophil-To-Lymphocyte Ratio as Predictive Factor of Overall Survival and Pattern of Recurrence in Patients With Colorectal Liver Metastases Treated With Potential Curative Surgery in a Post-Neoadjuvant Therapy Setting

HPB

Hepatology

Gastroenterology

2016

English

TOPK Inhibitor HI-TOP-32 Administration in DEN-induced Hepatocarcinogenesis in C57bl/6 Mice Results in Tumour Regression

English

Related publications

Peritumoral CD3+inflammation and Neutrophil to Lymphocyte Ratio Predict Overall Survival in Patients Affected by Colorectal Liver Metastases Treated With Surgery

English

Neutrophil‐to‐lymphocyte Ratio as a Prognostic Factor in Advanced Stage Ovarian Carcinoma Treated With Neoadjuvant Chemotherapy

International Journal of Gynecology and Obstetrics

English

Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases

British Journal of Cancer

Cancer Research

Oncology

2018

English

Is Neutrophil to Lymphocyte Ratio a Predictive Factor for Recurrence of Urethral Stricture?

Revista da Associacao Medica Brasileira

Medicine

2019

English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer

English

Combined Fibrinogen and Neutrophil–lymphocyte Ratio as a Predictive Factor in Resectable Colorectal Adenocarcinoma

Cancer Management and Research

Oncology

2018

English

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

Przeglad Gastroenterologiczny

Gastroenterology

2018

English

Preoperative Radiological Assessment of Pathologic Response in Colorectal Cancer Liver Metastases Treated With Neoadjuvant Therapy

English

The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients With Gastric Adenocarcinoma

Journal of Gastrointestinal Cancer

Oncology

Gastroenterology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Mudan

Neutrophil-To-Lymphocyte Ratio as Predictive Factor of Overall Survival and Pattern of Recurrence in Patients With Colorectal Liver Metastases Treated With Potential Curative Surgery in a Post-Neoadjuvant Therapy Setting

TOPK Inhibitor HI-TOP-32 Administration in DEN-induced Hepatocarcinogenesis in C57bl/6 Mice Results in Tumour Regression

Related publications

Peritumoral CD3+inflammation and Neutrophil to Lymphocyte Ratio Predict Overall Survival in Patients Affected by Colorectal Liver Metastases Treated With Surgery

Neutrophil‐to‐lymphocyte Ratio as a Prognostic Factor in Advanced Stage Ovarian Carcinoma Treated With Neoadjuvant Chemotherapy

Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases

Is Neutrophil to Lymphocyte Ratio a Predictive Factor for Recurrence of Urethral Stricture?

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Combined Fibrinogen and Neutrophil&ndash;lymphocyte Ratio as a Predictive Factor in Resectable Colorectal Adenocarcinoma

The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy

Preoperative Radiological Assessment of Pathologic Response in Colorectal Cancer Liver Metastases Treated With Neoadjuvant Therapy

The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients With Gastric Adenocarcinoma

Combined Fibrinogen and Neutrophil–lymphocyte Ratio as a Predictive Factor in Resectable Colorectal Adenocarcinoma